HYCROFT MINING HOLDING CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HYCROFT MINING HOLDING CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | Mar 12, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $0 | Mar 14, 2024 |
| FY2023 | Dec 31, 2022 | $33.23M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $110.73M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $47.04M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $13.71M | May 14, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($40.66M) | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | ($60.90M) | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | ($55.02M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | ($60.83M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($88.56M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($136.39M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($98.90M) | May 14, 2021 |
| FY2019 | Dec 31, 2018 | $1.68M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($2.8K) | Mar 25, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($44.47M) | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | ($43.82M) | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | ($45.01M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | ($53.49M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($83.91M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($89.37M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($33.94M) | May 14, 2021 |
| FY2019 | Dec 31, 2018 | ($609.6K) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($2.8K) | Mar 25, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.86M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $19.53M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $20.64M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $18.36M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $13.59M | Mar 28, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($82.87M) | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | ($35.90M) | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | ($41.45M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | ($34.86M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($37.04M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($110.51M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($59.77M) | May 14, 2021 |
| FY2019 | Dec 31, 2018 | ($452.7K) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($55) | Mar 25, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $564.0K | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $1.25M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $1.07M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $951.0K | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $6.99M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $33.44M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $12.30M | May 14, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $263.03M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $140.14M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $201.69M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $248.95M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $142.32M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $232.63M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $134.64M | May 14, 2021 |
| FY2019 | Dec 31, 2018 | $213.50M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $191.4K | Mar 25, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.33M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $173.55M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $189.04M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $185.65M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $210.82M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $216.01M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $573.89M | May 14, 2021 |
| FY2019 | Dec 31, 2018 | $8.04M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $169.2K | Mar 25, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $213.70M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | ($33.42M) | Mar 3, 2026 |
| FY2025 | Dec 31, 2023 | $12.66M | Mar 3, 2026 |
| FY2024 | Dec 31, 2022 | $63.31M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | ($68.49M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2020 | $16.62M | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | ($439.25M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | ($340.36M) | May 14, 2021 |
| FY2019 | Dec 31, 2017 | $22.2K | Mar 12, 2020 |
| FY2018 | Aug 27, 2017 | $0 | Mar 25, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($826.73M) | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | ($786.07M) | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | ($725.18M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | ($670.15M) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | ($609.32M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($520.76M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($444.44M) | May 14, 2021 |
| FY2019 | Dec 31, 2018 | $1.68M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($2.8K) | Mar 25, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $181.74M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $49.56M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $106.21M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $141.98M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $12.34M | Mar 28, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | $125.00M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | $144.90M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $135.00M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | $160.30M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $147.80M | Mar 31, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | (3) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | (3) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | (327) | May 14, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | (2) | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | (2) | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | (3) | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | (1) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | (3) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | (327) | May 14, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 83.03M | Mar 3, 2026 |
| FY2025 | Dec 31, 2024 | 24.88M | Mar 3, 2026 |
| FY2024 | Dec 31, 2023 | 20.74M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | 20.03M | Mar 14, 2024 |
| FY2022 | Dec 31, 2021 | 60.43M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | 59.90M | Mar 31, 2022 |
| FY2021 | May 29, 2020 | 50.16M | Mar 31, 2022 |
| FY2021 | May 28, 2020 | 2.90M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 323,328 | May 14, 2021 |